Cumulative body burdens of polycyclic aromatic hydrocarbons associated with estrogen bioactivation in pregnant women: Protein adducts as biomarkers of exposure

Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering

Volumn 49, Issue 6, 2014, Pages 634-640

  Lin, Che ^a,b   Chen, Dar Ren ^a   Wang, Shu Li ^c   Hsieh, Wei Chung ^d   Yu, Wen Fa ^d   Wang, Tzu Wen ^b   Tsai, Chen His ^b   Wei, Hz Han ^b   Tsuang, Ben Jei ^b   Lin, Po Hsiung ^b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d Da Chien General Hospital   (Taiwan)

Author keywords

naphthalene; Protein adducts; quinones; tissue dose

Indexed keywords

1 ,2-NAPHTHOQUINONE; 1 ,4-NAPHTHOQUINONE; CORRELATION COEFFICIENT; ENVIRONMENTAL EXPOSURE; ISOMERIC FORMS; NAPHTHOQUINONES; PROTEIN ADDUCTS; QUINONES;

BODY FLUIDS; KETONES; NAPHTHALENE; POLYCYCLIC AROMATIC HYDROCARBONS;

PROTEINS;

1,2 NAPHTHOQUINONE; 1,4 NAPHTHOQUINONE; ESTROGEN; ESTROGEN 2,3 QUINONE DERIVATIVE; ESTROGEN 3,4 QUINONE DERIVATIVE; NAPHTHALENE; QUINONE DERIVATIVE; SERUM ALBUMIN; UNCLASSIFIED DRUG; 1,2-NAPHTHOQUINONE; 1,4-NAPHTHOQUINONE; BENZOQUINONE; BENZOQUINONE DERIVATIVE; BIOLOGICAL MARKER; ESTRADIOL; ESTRADIOL-3,4-QUINONE; NAPHTHALENE DERIVATIVE; NAPHTHOQUINONE; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; BLOOD LEVEL; BODY BURDEN; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA ADDUCT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PROTEIN ADDUCT; PROTEIN CLEAVAGE; TAIWAN; ADULT; ANALOGS AND DERIVATIVES; BLOOD; BREAST TUMOR; CHEMICALLY INDUCED; CHEMISTRY; ENVIRONMENTAL EXPOSURE; METABOLISM; PREGNANCY;

ADULT; BENZOQUINONES; BIOLOGICAL MARKERS; BODY BURDEN; BREAST NEOPLASMS; ENVIRONMENTAL EXPOSURE; ESTRADIOL; FEMALE; HUMANS; NAPHTHALENES; NAPHTHOQUINONES; POLYCYCLIC HYDROCARBONS, AROMATIC; PREGNANCY; QUINONES; SERUM ALBUMIN; TAIWAN;

EID: 84896713038     PISSN: 10934529     EISSN: 15324117     Source Type: Journal    
DOI: 10.1080/10934529.2014.865416     Document Type: Article

References (45)

1. Bonner, M.R., Han, D., Nie, J., Rogerson, P., Vena, J.E., Muti, P., Trevisan, M., Edge, S.B., Freudenheim, J.L. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxymeasure. Cancer Epidemiol. Biomark. Prev. 2005, 14(1), 53-60
2. Devanesan, P.D., RamaKrishna, N.V., Todorovic, R., Rogan, E.G., Cavalieri, E.L., Jeong, H., Jankowiak, R., Small, G.J. Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro. Chem. Res. Toxicol. 1992, 5(2), 302-309
3. Marshall, C.J., Vousden, K.H., Phillips, D.H. Activation of c-Haras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide. Nature 1984, 310(5978), 586-589
4. Rodenhuis, S. Ras and human tumors. Semin. Cancer Biol. 1992, 3(4), 241-247
5. Van Der Schroeff, J.G., Evers, L.M., Boot, A.J., Bos, J.L. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J. Invest. Dermatol. 1990, 94(4), 423-425
6. Santodonato, J. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: Relationship to carcinogenicity. Chemosphere 1997, 34(4), 835-848
7. Buratti, M., Campo, L., Fustinoni, S., Cirla, P.E., Martinotti, I., Cavallo, D., Foa, V. Urinary hydroxylated metabolites of polycyclic aromatic hydrocarbons as biomarkers of exposure in asphalt workers. Biomarkers 2007, 12(3), 221-239
8. Seidel, A., Spickenheuer, A., Straif, K., Rihs, H.P.;Marczynski, B., Scherenberg, M., Dettbarn, G., Angerer, J.;Wilhelm, M., Bruning, T., Jacob, J., Pesch, B. New biomarkers of occupational exposure to polycyclic aromatic hydrocarbons. J. Toxicol. Environ. Health A 2008, 71(11-12), 734-745
9. Waidyanatha, S., Zheng, Y., Serdar, B., Rappaport, S.M. Albumin adducts of naphthalene metabolites as biomarkers of exposure to polycyclic aromatic hydrocarbons. Cancer Epidemiol. Biomark. Prev. 2004, 13(1), 117-124
10. Preuss, R., Angerer, J., Drexler, H. Naphthalene-An environmental and occupational toxicant. Int. Arch. Occup. Environ. Health 2003, 76(8), 556-576
11. Toxicology and Carcinogenesis Studies of Naphthalene (CAS No. 91-20-3) in B6C3F1 Mice (Inhalation Studies). Natl. Toxicol. Prog. Tech. Rep. Ser. 1992, 410, 1-172
12. Yang, Y., Sharma, R., Cheng, J.Z., Saini, M.K., Ansari, N.H., Andley, U.P., Awasthi, S., Awasthi, Y.C. Protection of HLE B-3 cells against hydrogen peroxide-And naphthalene-induced lipid peroxidation and apoptosis by transfection with hGSTA1 and hGSTA2.Invest. Ophthalmol. Vis. Sci. 2002, 43(2), 434-445
13. Bagchi, D., Bagchi, M., Balmoori, J., Vuchetich, P.J., Stohs, S.J. Induction of oxidative stress and DNA damage by chronic administration of naphthalene to rats. Res. Commun. Mol. Pathol. Pharmacol. 1998, 101(3), 249-257
14. Bagchi, M., Balmoori, J., Ye, X., Bagchi, D., Ray, S.D., Stohs, S.J. Protective effect of melatonin on naphthalene-induced oxidative stress and DNA damage in cultured macrophage J774A.1 cells. Mol. Cell Biochem. 2001, 221(1-2), 49-55
15. Schreiner, C.A. Genetic toxicity of naphthalene: A review. J. Toxicol. Environ. Health B Crit Rev. 2003, 6(2), 161-183
16. Toxicology and carcinogenesis studies of naphthalene (cas no. 91-20-3) in F344/N rats (inhalation studies). Natl. Toxicol. Prog. Tech. Rep. Ser. 2000, 500, 1-173
17. Feigelson, H.S., Henderson, B.E. Estrogens and breast cancer. Carcinogenesis 1996, 17(11), 2279-2284
18. Bolton, J.L., Thatcher, G.R. Potential mechanisms of estrogen quinone carcinogenesis. Chem. Res. Toxicol. 2008, 21(1), 93-101
19. Cavalieri, E., Frenkel, K., Liehr, J.G., Rogan, E., Roy, D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J. Natl. Cancer Inst. Monogr. 2000, 27, 75-93
20. Lavigne, J.A., Goodman, J.E., Fonong, T., Odwin, S., He, P., Roberts, D.W., Yager, J.D. The effects of catechol-Omethyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-Treated MCF-7 cells. Cancer Res. 2001, 61(20), 7488-7494
21. Yager, J.D. Endogenous estrogens as carcinogens throughmetabolic activation. J. Natl. Cancer Inst. Monogr. 2000, 27, 67-73
22. Hayes, C.L., Spink, D.C., Spink, B.C., Cao, J.Q., Walker, N.J., Sutter, T.R. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA 1996, 93(18), 9776-9781
23. Martucci, C.P., Fishman, J. P450 enzymes of estrogen metabolism. Pharmacol. Ther. 1993, 57(2-3), 237-257
24. Spink, D.C., Spink, B.C., Cao, J.Q., Gierthy, J.F., Hayes, C.L., Li, Y., Sutter, T.R. Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. J. Ster. Biochem. Mol. Biol. 1997, 62(2-3), 223-232
25. Butterworth, M., Lau, S.S., Monks, T.J. 17 beta-estradiol metabolism by hamster hepatic microsomes: Comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation. Chem. Res. Toxicol. 1996, 9(4), 793-799
26. Cao, K., Stack, D.E., Ramanathan, R., Gross, M.L., Rogan, E.G., Cavalieri, E.L. Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-Acetylcysteine, and glutathione. Chem. Res. Toxicol. 1998, 11(8), 909-916
27. Yager, J.D., Davidson, N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 2006, 354(3), 270-282
28. Parl, F.F., Dawling, S.;Roodi, N., Crooke, P.S. Estrogen metabolism and breast cancer: A risk model. Ann. NY Acad. Sci. 2009, 1155, 68-75
29. Convert, O.;Van Aerden, C., Debrauwer, L.;Rathahao, E.;Molines, H., Fournier, F., Tabet, J.C., Paris, A. Reactions of estradiol-2,3-quinone with deoxyribonucleosides: Possible insights in the reactivity of estrogen quinones with DNA. Chem. Res. Toxicol. 2002, 15(5), 754-764
30. Cavalieri, E.L., Stack, D.E., Devanesan, P.D., Todorovic, R., Dwivedy, I.;Higginbotham, S., Johansson, S.L., Patil, K.D.;Gross, M.L., Gooden, J.K., Ramanathan, R., Cerny, R.L., Rogan, E.G. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators, Proc. Natl.Acad. Sci.USA 1997, 94(20), 10937-10942
31. Cavalieri, E.L.;Devanesan, P.;Bosland, M.C.;Badawi, A.F.;Rogan, E.G. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: Implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 2002, 23(2), 329-333
32. Zahid, M.;Kohli, E., Saeed, M.;Rogan, E., Cavalieri, E. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: Implications for tumor-initiating activity. Chem. Res. Toxicol. 2006, 19(1), 164-172
33. Lin, P.H., Nakamura, J., Yamaguchi, S., Asakura, S., Swenberg, J.A. Aldehydic DNA lesions induced by catechol estrogens in calf thymus DNA. Carcinogenesis 2003, 24(6), 1133-1141
34. Waidyanatha, S., Rappaport, S.M. Hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naphthoquinone in SwissWebster mice. Chem. Biol. Interact. 2008, 172(2), 105-114
35. Lin, P.H., Chen, D.R.;Wang, T.W., Lin, C.H., Chuang, M.C. Investigation of the cumulative tissue doses of naphthoquinones in human serum using protein adducts as biomarker of exposure. Chem. Biol. Interact. 2009, 181(1), 107-114
36. Chen, D.R., Chen, S.T., Wang, T.W., Tsai, C.H., Wei, H.H., Chen, G.J., Yang, T.C., Lin, C., Lin, P.H. Characterization of estrogen quinone-derived protein adducts and their identification in human serum albumin derived from breast cancer patients and healthy controls. Toxicol. Lett. 2011, 202(3), 244-252
37. Wang, S.L., Chang, Y.C., Chao, H.R., Li, C.M., Li, L.A., Lin, L.Y., Papke, O. Body burdens of polychlorinated dibenzo-pdioxins, dibenzofurans, and biphenyls and their relations to estrogen metabolism in pregnant women. Environ. Health Perspect. 2006, 114(5), 740-745
38. Halliwell, B., Gutteridge, J.M. The importance of free radicals and catalytic metal ions in human diseases. Mol. Aspects Med. 1985, 8(2), 89-193
39. Waidyanatha, S.;Troester, M.A.;Lindstrom, A.B.;Rappaport, S.M. Measurement of hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naphthoquinone after administration of naphthalene to F344 rats. Chem. Biol. Interact. 2002, 141(3), 189-210
40. Huang, C.S., Lin, C.H., Lu, Y.S., Shen, C.Y. Unique features of breast cancer in Asian women-breast cancer in Taiwan as an example. J. Ster. Biochem. Mol. Biol. 2010, 118(4-5), 300-303
41. Boffetta, P., Nyberg, F. Contribution of environmental factors to cancer risk. Br. Med. Bull. 2003, 68, 71-94
42. Ishii, T., Nishimura, K., Nishimura, M. Administration of xenobiotics with anti-estrogenic effects results in mRNA induction of adult male-specific cytochrome P450 isozymes in the livers of adult female rats. J. Pharmacol. Sci. 2006, 101(3), 250-255
43. Shin, A., Kang, D., Choi, J.Y., Lee, K.M., Park, S.K., Noh, D.Y., Ahn, S.H., Yoo, K.Y. Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women. Exp. Mol. Med. 2007, 39(3), 361-366
44. Okobia, M.N., Bunker, C.H., Garte, S.J., Zmuda, J.M., Ezeome, E.R., Anyanwu, S.N., Uche, E.E., Osime, U., Ojukwu, J., Kuller, L.H., Ferrell, R.E., Taioli, E. Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: A case control study. Infect. Agent Cancer 4 Suppl. 2009, 1, S12
45. Brody, J.G., Moysich, K.B., Humblet, O., Attfield, K.R., Beehler, G.P., Rudel, R.A. Environmental pollutants and breast cancer: Epidemiologic studies. Cancer 2007, 109(12 Suppl), 2667-2711